ARS Pharmaceuticals (SPRY) Change in Inventory (2024 - 2026)
ARS Pharmaceuticals (SPRY) reported Change in Inventory of $294000.0 for Q1 2026, down 96.52% on a YoY basis from $8.4 million in Q1 2025, and down 96.97% sequentially from $9.7 million in Q4 2025.
ARS Pharmaceuticals (SPRY) Change in Inventory (2024 - 2026) Analysis & Trends
ARS Pharmaceuticals (SPRY) has 3 years of Change in Inventory data on file, last reported at $294000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Inventory fell 96.52% year-over-year to $294000.0; the trailing twelve-month figure through Mar 2026 stood at $13.8 million (down 3.91% YoY), and the FY2025 full-year result was $22.0 million, up 269.82% from the prior year.
- Change in Inventory fell to $294000.0 in Q1 2026, from $9.7 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $9.7 million in Q4 2025 to a low of -$963000.0 in Q3 2025.
- A 3-year average of $4.0 million and a median of $4.8 million in 2025 frame the typical range for Change in Inventory.
- Peak annual rise in Change in Inventory reached 68.64% in 2025, while the deepest fall reached 626.23% in 2025.
- Tracing SPRY's Change in Inventory over 3 years: stood at $5.8 million in 2024, then jumped by 68.64% to $9.7 million in 2025, then tumbled by 96.97% to $294000.0 in 2026.
- Business Quant data shows SPRY's Change in Inventory at $294000.0 in Q1 2026, $9.7 million in Q4 2025, and -$963000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 71.84 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 97.70 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -26.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | ARS Pharmaceuticals | 595.78 Mn | 394.81 Mn | - | 294,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 294,000.00 |
| Mar 31, 2026 | 294,000.00 |
| Dec 31, 2025 | 9.72 Mn |
| Dec 31, 2025 | 9.72 Mn |
| Sep 30, 2025 | -963,000.00 |
| Sep 30, 2025 | -963,000.00 |
| Jun 30, 2025 | 4.78 Mn |
| Jun 30, 2025 | 4.78 Mn |
| Mar 31, 2025 | 8.45 Mn |
| Mar 31, 2025 | 8.45 Mn |
| Dec 31, 2024 | 5.76 Mn |
| Dec 31, 2024 | 5.76 Mn |
| Sep 30, 2024 | 183,000.00 |
| Sep 30, 2024 | 183,000.00 |